HUMA – humacyte, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

HUMA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/1

07:20 am

huma

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Medium Report

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at HC Wainwright.

Report

12/1

07:20 am

huma

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Medium Report

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at UBS Group AG.

Report

11/21

08:05 am

huma

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $6.00 price target on the stock.

Medium Report

Humacyte (NASDAQ:HUMA) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $6.00 price target on the stock.

Report

11/21

06:11 am

huma

Rating for HUMA

Medium Report

Rating for HUMA

Report

11/13

01:32 pm

huma

Rating for HUMA

Low Report

Rating for HUMA

Report

11/13

01:32 pm

huma

Rating for HUMA

Low Report

Rating for HUMA

Report

10/13

07:59 am

huma

Rating for HUMA

High Report

Rating for HUMA

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.